By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarker services company Proteome Sciences said today that it will analyze samples and perform other services for Janssen Pharmaceutica, a Johnson & Jonson company that specializes in developing drugs for mental health conditions.

Under the contract with Janssen, Proteome Sciences will combine its TMT isobaric mass tag technology, sample preparation, and bioinformatics with mass spectrometry services using Thermo Fisher Scientific's Orbitrap Velos.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.